Gastroesophageal Reflux Disease (Gerd): Review Article
Abstract
Background: Millions of people across the world suffer from the common clinical illness known as gastroesophageal reflux disease (GERD). Symptoms that are both common and unique can be used to identify patients. Many GERD patients receive therapeutic relief with acid suppression therapy, which also shields them from harmful side effects. Objective: The review's primary goal is to highlight diagnostic and therapeutic approaches for manage and treating gastroesophageal reflux disease. Methods: We looked for data on [Gastroesophageal Reflux Disease, Diagnosis, Complications Treatment] at PubMed, Google Scholar, and Science Direct. However, only the most recent or extensive study was taken into account between August 1999 and Jun 2019. References from related works were also evaluated by the writers. There are not enough resources to translate documents into languages other than English, hence those documents have been ignored. It was generally agreed that documents such as unpublished manuscripts, oral presentations, conference abstracts, and dissertations did not qualify as legitimate scientific study. Conclusion: GERD is a frequent clinical issue that is associated with severe morbidity and a possible decline in quality of life. The prevention of GERD consequences depends on early diagnosis of symptoms. Its management continues to depend on behavioural adjustments and developments in acid suppression.
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.